Roche Granted Injunction Against Cipla for Trademark Infringement of Valcyte
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Swss drug maker Roche has been granted an injunction by the Bombay High Court against Cipla for trademark infringement of Roche's Valcyte (valgancyclovir), used in the treatment of HIV-related infections